MCID: TCH005
MIFTS: 20

Tièche-Jadassohn Nevus malady

Categories: Rare diseases, Neuronal diseases, Skin diseases

Aliases & Classifications for Tièche-Jadassohn Nevus

About this section

Aliases & Descriptions for Tièche-Jadassohn Nevus:

Name: Tièche-Jadassohn Nevus 47
Benign Mesenchymal Melanoma 47
Jadassohn-Tièche Syndrome 47
Jadassohn-Tièche Nevus 47
 
Blue Neuronevus 47
Mongolian Spot 67
Nevus, Blue 67
Blue Nevus 47

Classifications:



Summaries for Tièche-Jadassohn Nevus

About this section
Wikipedia:70 Blue nevus (also known as \"blue neuronevus,\" \"dermal melanocytoma,\" and \"nevus bleu\") is a type of... more...

MalaCards based summary: Tièche-Jadassohn Nevus, also known as benign mesenchymal melanoma, is related to carney complex variant and nevus of ota, and has symptoms including macule Affiliated tissues include lymph node, skin and endothelial.

Related Diseases for Tièche-Jadassohn Nevus

About this section

Diseases related to Tièche-Jadassohn Nevus via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 21)
idRelated DiseaseScoreTop Affiliating Genes
1carney complex variant10.9
2nevus of ota10.1
3melanoma metastasis9.8
4sarcoma9.8
5clear cell sarcoma9.8
6cutis verticis gyrata9.8
7orbital melanoma9.8
8spitz nevus9.8
9argyria9.8
10alopecia9.6
11cutaneous lupus erythematosus9.6
12ocular albinism9.6
13adenocarcinoma9.6
14hidradenoma9.6
15lupus erythematosus9.6
16alopecia areata9.6
17albinism9.6
18lentigo maligna melanoma9.6
19phacomatosis pigmentovascularis9.6
20pyogenic granuloma9.6
21subacute cutaneous lupus erythematosus9.6

Graphical network of the top 20 diseases related to Tièche-Jadassohn Nevus:



Diseases related to tièche-jadassohn nevus

Symptoms for Tièche-Jadassohn Nevus

About this section

UMLS symptoms related to Tièche-Jadassohn Nevus:


macule

Drugs & Therapeutics for Tièche-Jadassohn Nevus

About this section

Drugs for Tièche-Jadassohn Nevus (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 66)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Edetic Acidapproved, vet_approvedPhase 3, Phase 29560-00-4, 62-33-96049
Synonyms:
(ethylenedinitrilo)tetraacetic acid, ion(4−)
2,2',2'',2'''-(ethane-1,2-diyldinitrilo)tetraacetate
Acide ethylenediaminetetracetique
Acido edetico
Acidum edeticum
CaEDTA
Calcium Disodium Edetate (JAN)
Calcium Disodium Versenate
Calcium disodium versenate (TN)
 
EDT
EDTA
EDTA, ion(4-)
Edetate Calcium
Edetate calcium disodium (USP)
Ethylenediaminetetraacetate
Ethylenediaminetetraacetic acid
N,N'-1,2-Ethane diylbis-(N-(carboxymethyl)glycine)
acide edetique
{[-(bis-carboxymethyl-amino)-ethyl]-carboxymethyl-amino}-acetic acid
2
WarfarinapprovedPhase 345481-81-26691, 54678486
Synonyms:
(-)-Warfarin
(S)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone
(S)-Warfarin
(phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarin
(phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarine
1-(4'-Hydroxy-3'-coumarinyl)-1-phenyl-3-butanone
200 Coumarin
200 coumarin
3-(1'-Phenyl-2'-acetylethyl)-4-hydroxycoumarin
3-(Acetonylbenzyl)-4-hydroxycoumarin
3-(alpha-Acetonylbenzyl)-4-hydroxycoumarin
3-(alpha-Phenyl-beta-acetylaethyl)-4-hydroxycumarin
3-(alpha-Phenyl-beta-acetylethyl)-4-hydroxycoumarin
4-Hydroxy-3- (3-oxo-1-fenyl-butyl) cumarine
4-Hydroxy-3- (3-oxo-1-phenyl-butyl)-cumarin
4-Hydroxy-3-(3-oxo-1-fenyl-butyl) cumarine
4-Hydroxy-3-(3-oxo-1-phenyl-butyl)-cumarin
4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one
4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one
4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin
4-Idrossi-3- (3-oxo-)-fenil-butil)-cumarine
4-Idrossi-3-(3-oxo-)-fenil-butil)-cumarine
4-Idrossi-3-(3-oxo-1-fenil-butil)-cumarine
45706_FLUKA
45706_RIEDEL
4oh-coumarin deriv.
5543-56-6
5543-57-7
81-81-2
A2250_FLUKA
A2250_SIGMA
AC-15978
AC1L1N37
AC1Q6AN3
AR-1E2310
Arab Rat Death
Arab rat death
Arab rat deth
Athrombin
Athrombin-K
Athrombin-k
Athrombine-K
Athrombine-k
BRD-A24514565-001-02-2
BRD-A24514565-236-01-6
BRN 1293536
BSPBio_002026
Bio-0586
Brumolin
C01541
C19H16O4
CBDivE_002127
CBDivE_013236
CBKinase1_000192
CBKinase1_012592
CHEBI:10033
CHEMBL1464
CID6691
CO-Rax
Caswell No. 903
Choice
Choice (TN)
Co-Rax
Co-rax
Compound 42
Coumadin
Coumadin Tabs
Coumafen
Coumafene
Coumafene [French]
Coumaphen
Coumaphene
Coumarins
Coumefene
Cov-R-Tox
Cov-R-tox
D-Con
D08682
DB00682
DL-3-(alpha-acetonylbenzyl)-4-hydroxycoumarin
Dethmor
Dethnel
Dicusat E
Dicusat e
DivK1c_000444
EINECS 201-377-6
EINECS 226-907-3
EPA Pesticide Chemical Code 086002
Eastern states duocide
Fasco fascrat powder
Frass-Ratron
Frass-ratron
HMS1921K07
HMS2092C20
HMS501G06
HSDB 1786
I14-0958
IDI1_000444
Jantoven
KBio1_000444
KBio2_000674
KBio2_003242
KBio2_005810
KBio3_001526
KBioGR_000901
KBioSS_000674
Killgerm sewarin p
Kumader
Kumadu
Kumatox
Kypfarin
LS-55083
Latka 42
Latka 42 [Czech]
Liqua-tox
MLS001304042
Maag Rattentod Cum
Maag rattentod cum
Mar-Frin
Mar-frin
Marevan
Martin'S mar-frin
Martin's mar-frin
 
Maveran
MolPort-001-787-822
Mouse pak
NCGC00094810-01
NCGC00094810-02
NCGC00159398-03
NCGC00178855-01
NINDS_000444
NSC 59813
NSC59813
PS104_SUPELCO
Panwarfin
Place-Pax
Place-pax
Prothromadin
RAX
RCR grey squirrel killer concentrate
RCRA waste no. P001
Rat & mice bait
Rat and mice bait
Rat-B-gon
Rat-Gard
Rat-Kill
Rat-Mix
Rat-O-cide #2
Rat-O-cide no. 2
Rat-Ola
Rat-Trol
Rat-a-way
Rat-alpha-way
Rat-b-gon
Rat-beta-gon
Rat-gard
Rat-kill
Rat-mix
Rat-o-cide #2
Rat-ola
Rat-trol
Ratorex
Ratox
Ratoxin
Ratron
Ratron G
Ratron g
Rats-no-more
Ratten-Koederrohr
Ratten-koederrohr
Rattenstreupulver Neu Schacht
Rattenstreupulver neu schacht
Rattenstreupulver new schacht
Rattentraenke
Rattunal
Rcra waste number P001
Ro-Deth
Ro-deth
Rodafarin
Rodafarin C
Rodafarin c
Rodex
Rodex blox
Rosex
Rough & ready mouse mix
Rough and ready mouse mix
SMP1_000316
SMR000718754
SPBio_000870
SPECTRUM1500613
STK364490
Sakarat
Sewarin
Sofarin
Solfarin
Sorexa Plus
Sorexa plus
Spectrum2_000935
Spectrum3_000583
Spectrum4_000381
Spectrum5_001751
Spectrum_000194
Spray-trol brand roden-trol
Temus W
Temus w
Tintorane
Tox-Hid
Tox-hid
Twin light rat away
UNII-5Q7ZVV76EI
Vampirinip II
Vampirinip III
Vampirinip iii
W.A.R.F. 42
WARF compound 42
WLN: T66 BOVJ DYR&1V1 EQ
Waran
Warf 10
Warf 42
Warfarat
Warfarin (INN)
Warfarin (and salts of)
Warfarin Plus
Warfarin Q
Warfarin [BSI:ISO]
Warfarin [INN:BAN]
Warfarin plus
Warfarin plus [discontinued]
Warfarin sodium
Warfarin titrated to an INR of 2.5-3.0
Warfarin(R)
Warfarina
Warfarina [INN-Spanish]
Warfarine
Warfarine [INN-French]
Warfarine [ISO-French]
Warfarinum
Warfarinum [INN-Latin]
Warficide
Warfilone
Zoocoumarin
Zoocoumarin [Netherlands and USSR]
Zoocoumarin [Russian]
delta-Con
nchembio.307-comp19
rac-Warfarin
warfarin
3
DabrafenibapprovedPhase 3, Phase 27944462760, 44516822
Synonyms:
BRAF inhibitor GSK2118436
Dabrafenib
 
GSK2118436
GSK2118436a
Tafinlar
dabrafenib
4
nivolumabapprovedPhase 2, Phase 3326946414-94-4
Synonyms:
BMS-936558
 
MDX-1106
ONO-4538
nivolumab
5
TrametinibapprovedPhase 3, Phase 2121871700-17-311707110
Synonyms:
GSK 1120212
GSK1120212
JTP 74057
JTP-74057
 
MEK Inhibitor GSK1120212
Mekinist
Trametinib Dimethyl Sulfoxide
Trametinibum
trametinib
6
ApixabanapprovedPhase 3134503612-47-310182969
Synonyms:
1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahyd
2p16
503612-47-3
AKOS005146204
Apixaban
Apixaban (JAN/USAN/INN)
BMS 562247-01
BMS-562247
BMS-562247-01
BMS-562247-01, Apixaban
 
CHEBI:49620
CHEMBL231779
CID10182969
D03213
DB07828
GG2
S1593_Selleck
UNII-3Z9Y7UWC1J
apixabanum
apixabán
ro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid amide
7
protease inhibitorsPhase 35320
Synonyms:
 
protease inhibitors
8HIV Protease InhibitorsPhase 35319
9AnticoagulantsPhase 3, Phase 22516
10DabigatranPhase 3221
11Protein Kinase InhibitorsPhase 3, Phase 2, Phase 13612
12Serine Proteinase InhibitorsPhase 3850
13DextransPhase 3, Phase 299
14Pentetic AcidPhase 3, Phase 295
15AntithrombinsPhase 3672
16Chelating AgentsPhase 3, Phase 21365
17Blood SubstitutesPhase 3, Phase 2246
18Antithrombin IIIPhase 3665
19RadiopharmaceuticalsPhase 3, Phase 2485
20Technetium Tc 99m PentetatePhase 3, Phase 216
21Plasma SubstitutesPhase 3, Phase 2233
22Antibodies, MonoclonalPhase 2, Phase 33795
23ImmunoglobulinsPhase 2, Phase 36045
24AntibodiesPhase 2, Phase 36045
25Lipid Regulating AgentsPhase 32702
26AntimetabolitesPhase 311774
27Anticholesteremic AgentsPhase 31983
28Hydroxymethylglutaryl-CoA Reductase InhibitorsPhase 31956
29Hypolipidemic AgentsPhase 32721
30Interferon-alphaPhase 31139
31interferonsPhase 32137
32Antiviral AgentsPhase 39732
33Anti-Infective AgentsPhase 321402
34Factor Xa InhibitorsPhase 3391
35serineNutraceuticalPhase 3921
36Omega 3 Fatty AcidNutraceuticalPhase 3969
37MaceNutraceuticalPhase 349
38NutmegNutraceuticalPhase 349
39
Bevacizumabapproved, investigationalPhase 21968216974-75-3
Synonyms:
216974-75-3
Avastin
Avastin (TN)
Bevacizumab
Bevacizumab (genetical recombination)
 
Bevacizumab (genetical recombination) (JAN)
D06409
R-435
anti-VEGF monoclonal antibody
antiVEGF
bevacizumab
40
Aminolevulinic acidapprovedPhase 2157106-60-5137
Synonyms:
106-60-5
35BEC718-C970-426A-9859-BF58284C60B4
5-ALA
5-Amino-4-oxo-Pentanoate
5-Amino-4-oxo-Pentanoic acid
5-Amino-4-oxopentanoate
5-Amino-4-oxopentanoic acid
5-Amino-4-oxovalerate
5-Amino-4-oxovaleric acid
5-Amino-Levulinate
5-Amino-Levulinic acid
5-Aminolaevulinate
5-Aminolaevulinic acid
5-Aminolevulinate
5-Aminolevulinic acid
5-amino-levulinate
5451-09-2
AC-054
AC1L18K9
AKOS003587520
ALA
ALA-PDT
Aladerm
Amino-levulinic acid
Aminolevulinate
Aminolevulinic
Aminolevulinic acid
BIDD:GT0260
BSPBio_003407
C00430
CCRIS 8958
CHEBI:17549
CHEMBL601
CID137
CPD000857229
 
D07567
DALA
DB00855
DivK1c_006954
EINECS 203-414-1
I14-10101
KBio1_001898
KBio2_002062
KBio2_004630
KBio2_007198
KBio3_002627
KBioGR_001176
KBioSS_002062
Kerastick
LMFA01100055
LS-101793
Levulinic acid, 5-amino- (8CI)
MLS001333097
MLS001333098
MolPort-001-788-423
NCGC00178086-01
Pentanoic acid, 5-amino-4-oxo- (9CI)
SAM002589919
SMR000857229
SPBio_001843
ST50819610
SpecPlus_000858
Spectrum2_001662
Spectrum3_001654
Spectrum4_000618
Spectrum5_001505
Spectrum_001582
UNII-88755TAZ87
delta-ALA
delta-Aminolevulinate
delta-Aminolevulinic acid
delta-aminolevulinic acid
41Pharmaceutical SolutionsPhase 1, Phase 27793
42VaccinesPhase 2, Phase 16428
43MitogensPhase 21526
44Immunoglobulin GPhase 2265
45Endothelial Growth FactorsPhase 2362
46Angiogenesis Modulating AgentsPhase 24072
47Angiogenesis InhibitorsPhase 24143
48Dermatologic AgentsPhase 25674
49Photosensitizing AgentsPhase 2476
50OrangeNutraceuticalPhase 1, Phase 2249

Interventional clinical trials:

(show all 28)
idNameStatusNCT IDPhase
1Breast and Melanoma Trial With Lymphoseek to Identify Lymph NodesCompletedNCT01106040Phase 3
2Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and MelanomaCompletedNCT00671918Phase 3
3Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran EtexilateCompletedNCT00262600Phase 3
4Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With HypertriglyceridemiaRecruitingNCT02104817Phase 3
5Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by SurgeryRecruitingNCT02339571Phase 2, Phase 3
6Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 MelanomaRecruitingNCT02224781Phase 3
7Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by SurgeryActive, not recruitingNCT01274338Phase 3
8Phase III Acute Coronary SyndromeTerminatedNCT00831441Phase 3
9Fluorescein for Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Stage I and II Malignant MelanomaCompletedNCT00847522Phase 1, Phase 2
10Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in MelanomaCompletedNCT00101166Phase 2
11A Study Comparing Lymphoseek® and Vital Blue Dye as Lymphoid Tissue Targeting Agents in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node MappingRecruitingNCT02509598Phase 2
12Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by SurgeryRecruitingNCT02196181Phase 2
13Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by SurgeryRecruitingNCT01950390Phase 2
14Photodynamic Therapy Using Blue Light or Red Light in Treating Basal Cell Carcinoma in Patients With Basal Cell Nevus SyndromeActive, not recruitingNCT02258243Phase 2
15Second Echelon Node Study With Methylene BlueCompletedNCT01823172Phase 1
16An Expanded Cohort Trial of Bortezomib and Sorafenib in Advanced Malignant MelanomaCompletedNCT01078961Phase 1
17Immune Responses To Antigen-Bearing Dendritic Cells in Patients With MalignancyCompletedNCT00700167Phase 1
18Lymph Node Mapping Using Indocyanine Green Solution in Diagnosing Patients With Malignant MelanomaUnknown statusNCT01898403
19Infrared Lymphangiography as a Method of Sentinel Node IdentificationCompletedNCT02057393
20Intraoperative Mapping of Regional Lymphatics Draining the Primary Site of Melanoma Using Isosulfan BlueCompletedNCT00581698
21Sentinel Node With Ultrasound Contrast in MelanomaCompletedNCT00370136
22Lymphatic Anomalies RegistryRecruitingNCT02399527
23Family Study of Melanoma in ItalyRecruitingNCT00339222
24Registry for Vascular Anomalies Associated With CoagulopathyRecruitingNCT00576888
25Targeted Silica Nanoparticles for Image-Guided Intraoperative Sentinel Lymph Node Mapping in Head and Neck Melanoma, Breast and Cervical/Uterine Cancer PatientsRecruitingNCT02106598Early Phase 1
26Fluorescence Surgery for Sentinel Node Identification in MelanomaRecruitingNCT02142244
27Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus SyndromeActive, not recruitingNCT02157623
28Photodynamic Therapy for Treatment of Cutaneous Squamous Cell Carcinoma in SituNot yet recruitingNCT03025724

Search NIH Clinical Center for Tièche-Jadassohn Nevus

Genetic Tests for Tièche-Jadassohn Nevus

About this section

Anatomical Context for Tièche-Jadassohn Nevus

About this section

MalaCards organs/tissues related to Tièche-Jadassohn Nevus:

35
Lymph node, Skin, Endothelial

Animal Models for Tièche-Jadassohn Nevus or affiliated genes

About this section

Publications for Tièche-Jadassohn Nevus

About this section

Variations for Tièche-Jadassohn Nevus

About this section

Expression for genes affiliated with Tièche-Jadassohn Nevus

About this section
Search GEO for disease gene expression data for Tièche-Jadassohn Nevus.

Pathways for genes affiliated with Tièche-Jadassohn Nevus

About this section

GO Terms for genes affiliated with Tièche-Jadassohn Nevus

About this section

Sources for Tièche-Jadassohn Nevus

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet